Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma

Robert F. Hobbs, Richard L. Wahl, Eric C. Frey, Yvette Kasamon, Hong Song, Peng Huang, Richard J. Jones and George Sgouros
Journal of Nuclear Medicine September 2013, 54 (9) 1535-1542; DOI: https://doi.org/10.2967/jnumed.112.117952
Robert F. Hobbs
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric C. Frey
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvette Kasamon
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Song
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Huang
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Jones
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Sgouros
Johns Hopkins University, Baltimore Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 54 no. 9 1535-1542
DOI 
https://doi.org/10.2967/jnumed.112.117952
PubMed 
23918734

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 30, 2012
  • Accepted for publication April 8, 2013
  • Published online September 3, 2013.

Article Versions

  • previous version (August 5, 2013 - 05:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Robert F. Hobbs,
  2. Richard L. Wahl,
  3. Eric C. Frey,
  4. Yvette Kasamon,
  5. Hong Song,
  6. Peng Huang,
  7. Richard J. Jones and
  8. George Sgouros
  1. Johns Hopkins University, Baltimore Maryland
  1. For correspondence or reprints contact: Robert F. Hobbs, Department of Radiology, Johns Hopkins University, School of Medicine, CRB II 4M.60, 1550 Orleans St., Baltimore MD 21231. E-mail: rhobbs3{at}jhmi.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 17 Citations
  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy
    George Sgouros, Wesley E. Bolch, Arturo Chiti, Yuni K. Dewaraja, Dimitris Emfietzoglou, Robert F. Hobbs, Mark Konijnenberg, Katarina Sjögreen-Gleisner, Lidia Strigari, Tzu-Chen Yen, Roger W. Howell
    Journal of the ICRU 2021 21 1
  • Dosimetry for Radiopharmaceutical Therapy
    George Sgouros, Robert F. Hobbs
    Seminars in Nuclear Medicine 2014 44 3
  • Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
    Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico, Brian E. Zimmerman
    Journal of Nuclear Medicine 2021 62 Supplement 3
  • Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy
    Robert F. Hobbs, Roger W. Howell, Hong Song, Sébastien Baechler, George Sgouros
    Radiation Research 2014 181 1
  • Dosimetry in Radiopharmaceutical Therapy
    Joe O’Donoghue, Pat Zanzonico, John Humm, Adam Kesner
    Journal of Nuclear Medicine 2022 63 10
  • Radiopharmaceutical Therapy
    George Sgouros
    Health Physics 2019 116 2
  • Membrane and Nuclear Absorbed Doses from177Lu and161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study
    Alexandre Larouze, Mario Alcocer-Ávila, Clément Morgat, Christophe Champion, Elif Hindié
    Journal of Nuclear Medicine 2023 64 10
  • Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
    Stephan Walrand, François Jamar
    International Journal of Molecular Sciences 2021 22 15
  • The Role of Preclinical Models in Radiopharmaceutical Therapy
    George Sgouros, Robert F. Hobbs, Diane S. Abou
    American Society of Clinical Oncology Educational Book 2014 34
  • I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response
    Donika Plyku, Robert F. Hobbs, Di Wu, Carlos Garcia, George Sgouros, Douglas Van Nostrand
    Annals of Nuclear Medicine 2022 36 3

Article usage

Article usage: August 2013 to April 2025

AbstractFullPdf
Aug 2013309032
Sep 201311691783
Oct 2013370426
Nov 20132351020
Dec 201312936
Jan 201412749
Feb 20149869
Mar 2014731624
Apr 2014771715
May 2014441311
Jun 20144846
Jul 2014471110
Aug 20142597
Sep 201426914
Oct 20143035
Nov 201444411
Dec 20143847
Jan 20154176
Feb 20152271
Mar 20154656
Apr 20153316
May 20154766
Jun 20151972
Jul 201527310
Aug 20152461
Sep 20153141
Oct 20151297
Nov 20152223
Dec 201533103
Jan 20162996
Feb 201640412
Mar 201621013
Apr 201618147
May 2016251214
Jun 20162354
Jul 201616112
Aug 20161707
Sep 201628712
Oct 201624012
Nov 20162708
Dec 20162148
Jan 20173253
Feb 20171221
Mar 20172328
Apr 20171920
May 20172415
Jun 20171021
Jul 20171530
Aug 20171524
Sep 20171245
Oct 201719118
Nov 20171722
Dec 20171835
Jan 20181052
Feb 20181063
Mar 20181541
Apr 20181298
May 20181137
Jun 2018726
Jul 20181300
Aug 20181111
Sep 2018701
Oct 20181013
Nov 2018724
Dec 2018839
Jan 20191024
Feb 2019703
Mar 2019825
Apr 20199211
May 20191017
Jun 2019821
Jul 2019924
Aug 2019913
Sep 2019901
Oct 20191036
Nov 20191263
Dec 2019924
Jan 2020910
Feb 2020967
Mar 20201034
Apr 20201230
May 20201144
Jun 20201943
Jul 2020711
Aug 2020501
Sep 2020521
Oct 2020944
Nov 2020816
Dec 20201095
Jan 20212711
Feb 20217126
Mar 2021362
Apr 20213153
May 2021495
Jun 20218116
Jul 202121212
Aug 202141016
Sep 20212113
Oct 202151223
Nov 2021131023
Dec 202142211
Jan 202271616
Feb 20226205
Mar 2022298
Apr 20224108
May 20222158
Jun 2022379
Jul 20221253
Aug 20221148
Sep 202251114
Oct 202211210
Nov 20223112
Dec 2022483
Jan 202342212
Feb 20235198
Mar 20237167
Apr 20232171
May 2023386
Jun 20235138
Jul 20236139
Aug 202311011
Sep 20236916
Oct 20231142
Nov 2023346
Dec 20239208
Jan 20243157
Feb 20242664
Mar 20243462
Apr 2024174725
May 202462613
Jun 202462011
Jul 202451619
Aug 2024162317
Sep 2024141917
Oct 202452819
Nov 20246135
Dec 20246243
Jan 20253158
Feb 20251838
Mar 202545015
Apr 202552914
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (9)
Journal of Nuclear Medicine
Vol. 54, Issue 9
September 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma
Robert F. Hobbs, Richard L. Wahl, Eric C. Frey, Yvette Kasamon, Hong Song, Peng Huang, Richard J. Jones, George Sgouros
Journal of Nuclear Medicine Sep 2013, 54 (9) 1535-1542; DOI: 10.2967/jnumed.112.117952

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma
Robert F. Hobbs, Richard L. Wahl, Eric C. Frey, Yvette Kasamon, Hong Song, Peng Huang, Richard J. Jones, George Sgouros
Journal of Nuclear Medicine Sep 2013, 54 (9) 1535-1542; DOI: 10.2967/jnumed.112.117952
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
  • MIRD Pamphlet No. 31: MIRDcell V4--Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
  • Membrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting--A Monte Carlo Study
  • Membrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting--A Monte Carlo Study
  • Dosimetry in Radiopharmaceutical Therapy
  • Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
  • Novel Treatment Strategies for Cancer and Their Tumor-targeting Approaches Using Antibodies Against Tumor-associated Antigens
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

Keywords

  • radiopharmaceutical therapy
  • dosimetry
  • treatment planning
  • BED
  • lymphoma
SNMMI

© 2025 SNMMI

Powered by HighWire